Boehringer Ingelheim Turkey brings together healthcare professionals for pulmonary fibrosis awareness
Pulmonary fibrosis was addressed at an event held with the participation of healthcare professionals and associations, and a book featuring the real-life stories of patients was introduced.
At an event spearheaded by Boehringer Ingelheim Turkey, the impacts of pulmonary fibrosis on patients' lives, diagnosis and treatment processes, and interdisciplinary collaboration were discussed.
Event Details and Stakeholders
Hosted by writer and voice actor Yekta Kopan, the gathering was held with the participation of civil society organizations in the healthcare field.
The Association of Research-Based Pharmaceutical Companies, the Pulmonary Hypertension and Scleroderma Patients Association, and the Federation of Rare Diseases took part in the event.
The Book 'Beyond the Scars' Was Introduced
Within the scope of the event, the work titled 'Beyond the Scars' was introduced to participants and the real struggles of patients were shared.
The life stories of Edip Özdener and Hasan Hüseyin Eşsiz, who live in different cities, found a place in the book.
Executive Statements and Approach
Boehringer Ingelheim Turkey General Manager Okan Güner stated that they aim to contribute to people living healthier and longer lives.
Güner expressed that making patients' voices heard and making the problems they encounter visible are among their fundamental responsibilities.
Rheumatological Dimension and Symptoms
Rheumatology Specialist Prof. Dr. Nevsun İnanç noted that rheumatoid arthritis is a systemic disease that can lead to involvement in various organs, including the lungs.
İnanç drew attention to the fact that complaints such as a chronic cough, shortness of breath, and difficulty breathing can be early findings.
Chest Diseases and Early Diagnosis
Chest Diseases Specialist Prof. Dr. Özlem Kumbasar stated that during the disease process, tissue thickens and hardens, resulting in a loss of elasticity.
Kumbasar emphasized that the earlier the diagnosis is made, the better the lungs can be protected, and noted that there are medications available to slow down the progression.